Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer

Australasian Radiology

Volumn 48, Issue 4, 2004, Pages 493-501

  Skala, Marketa ^a,g   Berry, M ^a   Duchesne, G ^c   Gogna, K ^e   Tai, Keen Hun ^c   Turner, S ^b   Kneebone, A ^a   Rolfo, A ^d   Haworth, A ^f  

^a Liverpool Health Service   (Australia)

^b Westmead and Nepean Hospitals   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d AUSTIN HEALTH   (Australia)

^e Queensland Radium Institute   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^g PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

3 D conformal therapy; Consensus development conference; Dose escalation; Practice guidelines; Prostatic neoplasms

Indexed keywords

AUSTRALIA; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HUMAN; IATROGENIC DISEASE; MALE; MANDATORY REPORTING; MEDICAL PRACTICE; NEW ZEALAND; ONCOLOGY; ORGANIZATION; OUTCOMES RESEARCH; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY CONTROL; RADIATION DOSE; RADIATION INJURY; REVIEW; RISK ASSESSMENT; SIMULATION; STANDARD; THREE DIMENSIONAL COMPUTER ASSISTED RADIOTHERAPY; TREATMENT PLANNING; WORKSHOP;

AUSTRALIA; HUMANS; MALE; NEW ZEALAND; PATIENT SELECTION; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 11144289979     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2004.01354.x     Document Type: Review

References (30)

1. Dearnaley DP, Khoo VS, Norman AR et al. Comparison of radiation side-effects of conformai and conventional radiotherapy in prostate cancer: a randomized trial. Lancet 1999; 353: 267-72.
2. Koper PC, Stroom JC, van Putten WP et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomized study. Int J Radiat Oncol Biol Phys 1999; 43: 727-34.
3. Pollack A, Zagars GK, Starkschall G et al. Prostate cancer radiation dose-response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097-105.
4. Hanks GE, Hanlon AL, Schultheiss TE et al. Dose escalation with 3D conformai treatment: Five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998; 41: 501-10.
5. Fiveash JB, Hanks G, Roach M et al. 3D conformal radiation therapy (3DCRT) for high-grade prostate cancer: a multi-institutional review. Int J Radiat Oncol Biol Phys 2000; 47: 335-42.
6. Zelefsky MJ, Leibel SA, Gaudin PB et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491-500.
7. Tai K-H, Duchesne G, Turner S et al. Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop. Australas Radiol 2004; 48: 502-508.
8. Brundage M, Lukka H, Crook J et al. The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systemic review. Radiother Oncol 2002; 64: 239-50.
9. Weber DC, Nouet P, Rouzaud M, Miralbell R. Patient positioning in prostate radiotherapy: is prone better than supine? Int J Radiat Oncol Biol Phys 2000; 47: 365-71.
10. Greer PB, Mortensen TM, Jose CC. Comparison of two methods for anterior-posterior isocentre localization in pelvic radiotherapy using electronic portal imaging. Int J Radiat Oncol Biol Phys 1997; 41: 1193-9.
11. Malone S, Szanto J, Perry G et al. A prospective comparison of three systems of patient immobilization for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2000; 48: 657-65.
12. Wu J, Haycocks T, Alasti H et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 2001; 61: 127-33.
13. Malone S, Donker R, Broader M et al. Effects of urethrography on prostate position: considerations for radiotherapy treatment planning of prostate. Int J Radiat Oncol Biol Phys 1999; 46: 89-93.
14. Kestin L, Goldstein N, Vicini F, Van D, Korman H, Martinez A. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys 2002; 54: 686-97.
15. International Commission on Radiation Units and Measurements (ICRU). Prescribing, Recording, and Reporting Photon Beam Therapy, Report 50. ICRU, Washington DC, 1992.
16. Boersma LJ, van den Brink M, Bruce AM et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-Volume histograms. Int J Radiat Oncol Biol Phys 1998; 41: 83-92.
17. van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000; 7: 1121-35.
18. Bel A, Vos PH, Rodrigus PT et al. High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys 1996; 35: 321-32.
19. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000; 48: 635-42.
20. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.
21. Kupelian PA, Buschbaum JC, Reddy CA, Klein EA. Radiation dose-response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason ≤ 6, and pre-treatment prostate-specific antigen 10). Int J Radiat Oncol Biol Phys 2001; 50: 621-5.
22. Zelefsky MJ, Happersett L, Liebel SA et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimentional conformal radiotherapy. Int J. Radiat Oncol Biol Phys 1997; 37: 13-19.
23. Wachter S, Gerstner N, Dorner D et al. The influence of a rectal balloon tube as internal immobilization device on variations of Volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002; 52: 91-100.
24. Khoo SV, Bedford JL, Webb S, Dearnaley DP. Comparison of 2D and 3D algorithms for adding a margin to the gross tumour volume in the conformal radiotherapy planning of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 42: 673-9.
25. Merrick GS, Butler WM, Wallner KE et al. The importance of radiation doses to the penile bulb vs crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 2002; 54: 1055-62.
26. Fiorino C, Reni M, Bolognese A, Cattaneo GM, Calandrino R. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol 1998; 47: 285-92.
27. Roach M, DeSilvio M, Lawton C et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003; 21: 1904-11.
28. Jackson A, Skwarchuk MW, Zelefsky MJ et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 2001; 49: 685-98.
29. Ryu JK, Winter K, Michalski JM et al. Interim report of toxicity from 3D conformai radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys 2002; 54: 1036-46.
30. See A, Kron T, Johansen J et al. Decision-making models in the analysis of portal films: a clinical pilot study. Australas Radiol 2000; 44: 72-83.